|
[ SBML Homepage | Home ]
(misc header text) |
|
[ SBML Homepage | Home ]
(misc header text) |
|
Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE,
Differential risk of tuberculosis reactivation among anti-TNF
therapies is due to drug binding kinetics and permeability and not
apoptotic and cytolytic activities,
J. Immunology, 2012, The Journal of Immunology, April 1, vol. 188, no. 7, pp. 3169-3178,
DOI: doi:10.4049/jimmunol.1103298,
PMID: 22379032,
PMCID: 352958
TNFmechanism.xml.zip, (Next text entry) |
|
|
|
|